Strategies to avoid virus transmissions by biopharmaceutic products

Archives of Virology, Supplement

Volumn 1997, Issue 13, 1997, Pages 245-256

  Werz, W ^a   Hoffmann, H ^a   Haberer, K ^b   Walter, J K ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^b SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ANIMAL; ARTICLE; BOVINE SPONGIFORM ENCEPHALOPATHY; CATTLE; CELL LINE; DISEASE TRANSMISSION; DRUG CONTAMINATION; FEMALE; HAMSTER; HEATING; HUMAN; QUALITY CONTROL; RISK ASSESSMENT; SAFETY; STANDARD; SYRIAN HAMSTER; VIROLOGY; VIRUS INFECTION;

ANIMALS; CATTLE; CELL LINE; CONSUMER PRODUCT SAFETY; CRICETINAE; DRUG CONTAMINATION; ENCEPHALOPATHY, BOVINE SPONGIFORM; FEMALE; HEATING; HUMANS; MESOCRICETUS; PHARMACEUTICAL PREPARATIONS; QUALITY CONTROL; RISK ASSESSMENT; VIRUS DISEASES;

EID: 0031309824     PISSN: 09391983     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-3-7091-6534-8_23     Document Type: Article

References (9)

1. BGA (1994) Bekanntmachung der Sicherheitsanforderungen an Arzneimittel aus Körperbestandteilen von Rind, Schaf oder Ziege zur Übertragung von BSE bzw. Scrapie. Bundesanzeiger Nr. 40, 26. Februar 1994
2. Charm SE, Landan S, Williams B, Hovowitz B, Prince AM, Pascual D (1992) High-temperature short-time heat inactivation of HIV and other viruses in human blood pharma. Vox Sang 62: 12-20
3. CPMP (1992) Guidelines for minimizing the risk of transmitting agents causing spongiform encephalopathy via medicinal products. Biologicals 20: 155-158
4. Golden RF (1994) Microwave purification for viral inactivation and bioprocess validation. Gene Eng News, May 15,17
5. Kimberlin RH, Walker C (1977) Characteristics of a short incubation model of scrapie into the golden hamster. J Gen Virol 34: 295-304
6. Pocchiari M (1991) Methodological aspects of the validation of purification procedures of human/animal derived products to remove unconvential slow viruses. Dev Biol Standard 75: 87-95
7. Taguehi H, Humphrey A (1966) Dynamic measurement of the volumetric oxygen transfer coefficient in fermentation systems. J Ferment Technol 44: 881-889
8. Walter JK, Werz, W, Berthold W (1992) Virus removal and inactivation. Concept and data for process validation of downstream processing. Biotech Forum Europe 9: 560-564
9. Walter JK, Werz W, Berthold W (1996) Process scale considerations in evaluation studies and scale-up. In: Brown F, Lubiniecki AS (eds) Viral safety and evaluation of viral clearance from biopharmaceutical products. S. Karger, Basel, pp 99-108